Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

3.425 -0.125 (-3.52%)
Streaming Delayed Price Updated: 2:31 PM EDT, Mar 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript ↗
MRVI earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research
From Maravai LifeSciences, Inc.
Via Business Wire
News headline image
Maravai LifeSciences Reports Third Quarter 2024 Financial Results
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai LifeSciences Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) ↗
 
Via Benzinga
News headline image
TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase
From TriLink BioTechnologies
Via Business Wire
News headline image
Cygnus Technologies and TriLink BioTechnologies® Collaborate to Launch AccuRes™ Host Cell DNA Quantification Kits
From TriLink BioTechnologies
Via Business Wire
News headline image
Unveiling 4 Analyst Insights On Maravai LifeSciences ↗
 
Via Benzinga
News headline image
Where Maravai LifeSciences Stands With Analysts ↗
 
Via Benzinga
News headline image
Wall Street Ticks Up As Consumer Sentiment Improves; Gold Hits Record Highs, Boosting Mining Stocks: What's Driving Markets Friday? ↗
Wall Street edged slightly higher on Friday, with major equity indices showing modest gains at midday in New York. 
Via Benzinga
News headline image
Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript ↗
MRVI earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Maravai LifeSciences Reports Second Quarter 2024 Financial Results
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai LifeSciences Appoints Trey Martin to Board of Directors
Maravai announces the appointment of CEO Trey Martin to its Board of Directors, highlighting his leadership, commitment to innovation, and industry experience 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
From TriLink BioTechnologies
Via Business Wire
News headline image
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript ↗
MRVI earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
MRVI Stock Earnings: Maravai LifeSciences Beats EPS, Beats Revenue for Q1 2024 ↗
MRVI stock results show that Maravai LifeSciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Maravai LifeSciences Reports First Quarter 2024 Financial Results
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation 
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
From TriLink BioTechnologies
Via Business Wire
News headline image
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
From TriLink BioTechnologies
Via Business Wire
News headline image
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session. 
Via Benzinga
Topics Stocks
Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report
Via AB Newswire
Topics Regulatory Compliance
News headline image
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
Market Momentum: NASDAQ SmallCaps Sparking Waves in March 2024: CELZ, DYAI, GROM, VTAK, BREA
Via AB Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.